David J. Lockhart
2012
In 2012, David J. Lockhart earned a total compensation of $1.1M as Chief scientific officer at Amicus Therapeutics, a 5% increase compared to previous year.
Compensation breakdown
| Bonus | $135,756 |
|---|---|
| Option Awards | $588,967 |
| Salary | $390,104 |
| Other | $13,280 |
| Total | $1,128,107 |
Lockhart received $589K in option awards, accounting for 52% of the total pay in 2012.
Lockhart also received $135.8K in bonus, $390.1K in salary and $13.3K in other compensation.
Rankings
In 2012, David J. Lockhart's compensation ranked 5,656th out of 11,487 executives tracked by ExecPay. In other words, Lockhart earned more than 50.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,656 out of 11,487 | 51st |
Division Manufacturing | 2,008 out of 4,253 | 53rd |
Major group Chemicals And Allied Products | 485 out of 1,198 | 60th |
Industry group Drugs | 326 out of 920 | 65th |
Industry Pharmaceutical Preparations | 255 out of 700 | 64th |
Source: SEC filing on April 28, 2014.
Lockhart's colleagues
We found five more compensation records of executives who worked with David J. Lockhart at Amicus Therapeutics in 2012.
2012
John Crowley
Amicus Therapeutics
Chief Executive Officer
2012
William Baird
Amicus Therapeutics
Chief Financial Officer
2012
Bradley Campbell
Amicus Therapeutics
Chief Operating Officer
2012
Pol Boudes
Amicus Therapeutics
Chief Medical Officer
2012
Daphne Quimi
Amicus Therapeutics